CEL-SCI Corporation Stock NYSE
Stocks
US1508375086
Biotechnology & Medical Research
| Market Cap | 29.55M 25.99M 24.5M 22.35M 41.81M 2.84B 42.13M 294M 114M 1.44B 111M 109M 4.7B | P/E 2026 * |
-0.55x | P/E 2027 * | -0.26x |
|---|---|---|---|---|---|
| Enterprise Value | 24M 21.11M 19.9M 18.15M 33.95M 2.3B 34.21M 239M 92.52M 1.17B 90.09M 88.14M 3.81B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 4.05x |
| Free-Float |
96.32% | Yield 2026 * |
-
| Yield 2027 * | - |
| 19/07/23 | Wall Street sluit hoger | |
| 19/07/23 | Wall Street op winst | |
| 18/07/23 | Wall Street richting licht rode opening | |
| 18/07/23 | Futures voorspellen terughoudende opening Wall Street | |
| 29/06/21 | Cel-Sci presenteert positieve onderzoeksdata immunotherapie |
| 1 day | -0.36% |
| Manager | Title | Age | Since |
|---|---|---|---|
Geert Kersten
CEO | Chief Executive Officer | 67 | 01/01/1995 |
Patricia Prichep
DFI | Director of Finance/CFO | 75 | 13/11/2024 |
| Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Geert Kersten
BRD | Director/Board Member | 67 | 01/01/1995 |
| Director/Board Member | 73 | 22/06/2015 | |
Bob Watson
CHM | Chairman | 69 | 08/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -14.33% | - | - | 29.55M | |
| -3.30% | +2.97% | +54.99% | +104.15% | 74.18B | |
| -0.12% | -3.82% | +34.21% | +74.94% | 59.55B | |
| +1.08% | -3.31% | -14.98% | +365.01% | 25.84B | |
| +0.05% | -0.10% | -1.19% | -4.42% | 24.73B | |
| -1.05% | +1.07% | +21.45% | -10.04% | 20.87B | |
| -1.70% | -4.15% | +147.82% | +325.69% | 15.32B | |
| +1.08% | -1.90% | +47.47% | +162.85% | 14.06B | |
| -0.21% | -7.96% | -20.44% | +749.48% | 13.12B | |
| -0.18% | -3.86% | +20.37% | +240.38% | 11.85B | |
| Average | -0.46% | -0.80% | +32.19% | +223.12% | 28.84B | |
| Weighted average by Cap. | -0.99% | -0.22% | +34.88% | +159.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5.97M 5.25M 4.95M 4.52M 8.45M 573M 8.51M 59.42M 23.03M 292M 22.42M 21.94M 949M |
| Net income | -25.08M -22.06M -20.8M -18.98M -35.49M -2.41B -35.76M -250M -96.72M -1.23B -94.18M -92.14M -3.99B | -29.51M -25.96M -24.47M -22.33M -41.76M -2.83B -42.08M -294M -114M -1.44B -111M -108M -4.69B |
| Net Debt | -5.55M -4.89M -4.61M -4.2M -7.86M -533M -7.92M -55.26M -21.42M -271M -20.85M -20.4M -883M | -5.34M -4.7M -4.43M -4.04M -7.55M -513M -7.61M -53.13M -20.59M -261M -20.05M -19.61M -849M |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
